Mood Disorders and Antidepressant Drugs Flashcards
what is used to classify mental health conditions
DSM5
depressive disorders
disruptive mood dysregulation disorder
major depressive disorder - single+recurrent
premenstrual dysphoric disorder
substance/medication induced depressive disorder
depressive disorder due to another medical condition
other specified depressive disorder
unspecified depressive disorder
is bipolar disorder classified as a depressive disorder on DSM5
no
bipolar disorder
alternation of depressive episodes and mania
depression symtoms
psychomotor retardation
fatigue or energy loss
decr concentration
decr interest in social activity
agitation
depressed mood
guilt and worthlessness
suicidal ideation
insomnia or hypersomnia
weight loss and decr appetite
lack of interest
anhedonia
anhedonia
decr ability to experience pleasure
does depression have a possible genetic link
yes
which NT systems are associated with mood disorders
noradrenergic
seratonergic
possibly dopaminergic
brain regions associated with depression
amygdala
prefrontal cortex
striatum
hippocampus
how does metabolism and glucose consumption in the brain change with depression
decrease
which region of the brain has the most significant loss of grey matter volume and white matter volume in depression
grey - subgenual anterior cingulate cortex
white - hippocampus
how is cortex size effected by depression
decreased thickness
default mode network
network of brain regions active when brain is at wakeful rest
what is believed to cause pattern of negative and self reference thoughts in depression
increased connectivity within and of DMN
what type of NT signalling can be impaired by stress
glutamatergic
which brain areas are hyperactive in depression
hippocampus
amygdala
subgenual cingulate cortex
medial prefrontal cortex
what is the effect of hypoactivity in the venterolateral and dorsolateral prefrontal cortices
impaired cognitive control on other brain regions leading to rumination
classes of antidepressants
tricyclic
reversible+irreversible MOA inhibitors
SSRIs
serotonin noradrenaline reuptake inhibitors SNRIs
noradrenaline reuptake inhibitors NARIs
noradrenergic and specific serotonergic antidepressants NaSSA
serotonin antagonist and reuptake inhibitor SARI
agomelatine
tricyclic antidepressant mechanism and targets
inhibit amine reuptake
H1 histamine, muscarinic, alpha1+2 adrenergic, 5HT
what effects are caused by tricyclic antidepressant overdose
cardiotoxicity
tricyclic antidepressant adverse effects
dry mouth
blurred vision
constipation
urinary retention
narrow angle glaucoma
fatigue
sedation
weight gain
postural hypotension
dizziness
loss of libido
arrhythmia
monoamine oxidase inhibitor mechanism and targets
irreversibly inhibit monoamine oxidase
MOAa and MOAb
what type of depression are monoamine oxidase inhibitors used to treat
atypical - with anxiety, phobia, hypochondria